SNAP-CAR utilizes benzylguanine-linked antibody adapters for precise and switchable antigen recognition across multiple targets. The platform is being explored in T and NK cells, with potential applications in both oncology and autoimmune disease.

Advancing the Next Generation of Immune Cell Therapy At Coeptis Therapeutics, we’re developing SNAP-CAR, a modular, adapter-directed cell therapy platform designed to offer control and flexibility in targeting disease.

“Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Announce Licensing Agreement” $COEP announces a major step forward in next-gen cell therapy with Monarch Therapeutics — advancing SNAP-CAR NK platform with cutting-edge adaptor

COEPTIS & Z Squared Announce Merger” https://t.co/uaHmVx6UZb This signifies not just a new chapter, but a dynamic evolution set to aim to create the largest publicly-traded Dogecoin-focused mining company in the world along with other assets such as Litecoin & continue our Tech &

As COEPTIS continues to bring our stakeholders updates & value, we prepare for more major milestones on the horizon & would like to thank you for all of your constant support in our new successful journey into Artificial Intelligence, Technologies, Crypto Currency, Blockchain,

“COEPTIS Partners with NexGenAI Solutions Group to Launch New AI Co-Working Hub in India, Driving Global Innovation in Technology” $COEP announces another major milestone launching a new High Tech Cutting-Edge AI & Blockchain Hub in India 🇮🇳 https://t.co/N7U93Zw6HV #Ai

COEPTIS enters a new week preparing to update you on more great strides $COEP & COEP Venture Group is making in artificial intelligence #Biotechnology and more! Updates on the way! #COEPVentures #AiNews #OpenAi #Blockchain #Token #Coeptis #Ai #Technology #Aitechnology #MLM

COEPTIS continues to build our new brand as a pioneering technology firm at the forefront of artificial intelligence & innovative biotechnology solutions partnering with companies in Blockchain, cryptocurrency, defense, biotechnologies while integrating our cutting-edge AI-driven

“COEPTIS, Inc. Establishes GEAR Therapeutics to Advance Innovative Cancer Cell Therapy into First-in-Human Studies” We are pleased to bring you more advancements in our biotechnology & innovative treatments in Cancer care. https://t.co/UntqAQB5nf #Coeptis $COEP #cancer

“COEPTIS’ NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan” $COEP ends the week with bringing you todays press and partnership with $BURU: https://t.co/xa94ODBtgl #OpenAi $COEP #COEPVentures #AiNews

“COEPTIS NexGenAI Affiliates Network & @MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing” $COEP brings you another partnership revolutionizing Ai marketing! https://t.co/albkeHsxZ0 #COEPVentures #AiNews #OpenAi #Blockchain #Token

Last week, COEPTIS introduced you to the launch of the COEP Venture Group which will be investing in AI, RPA & AI Agent Startups following the $500B to be invested into U.S Ai infrastructure. Stay with us as we will continue to bring you more exciting updates as we roll out our

“COEPTIS Announces the Launch of COEP Venture Group to Invest in AI, RPA, and AI Agent Startups” $COEP announces another milestone in joining the $700B+ global Ai Market. https://t.co/EfP7xDe4qL #OpenAi #COEPVentures #AiNews #Blockchain #Token #Coeptis #Ai #Technology